| Literature DB >> 28122802 |
Jiasian Teh1, Ned Kinnear1, Hannah Douglass-Molloy2, Derek Barrry Hennessey1.
Abstract
A 49-year-old woman with cutaneous and uterine leiomyomas, flank pain and a family history of hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome sought genetic testing. She was found to harbour a fumarate hydratase (FH) genetic mutation and a previously undetected renal tumour. The patient underwent radical nephrectomy, and remains well at follow-up. HLRCC syndrome is a rare autosomal dominant disease, with patients at increased risk for cutaneous leiomyomas, early-onset uterine leiomyomas and aggressive renal carcinoma. Although the syndrome may manifest life-threatening complications, outcomes may be improved by preventative family screening and surveillance, compelling early diagnosis. 2017 BMJ Publishing Group Ltd.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28122802 PMCID: PMC5278315 DOI: 10.1136/bcr-2016-218270
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X